Skip to main content

Rapid decline in the efficiency of HIV drug resistance genotyping from dried blood spots (DBS) and dried plasma spots (DPS) stored at 37 degrees C and high humidity.

García-Lerma JG, McNulty A, Jennings C, Huang D, Heneine W, Bremer JW

Publication: J Antimicrob Chemother (2009) • Vol 64 • Page 33-6PMID: 19403653View on PubMed

Purpose

The purpose of this paper was to determine the effects of extreme storage conditions on HIV amplification and genotyping from dried blood spots (DBS) and dried plasma spots (DPS).

Conclusion

The use of DPS resulted in increased failures when compared to DBS independent of the storage temperature or method used. Storage at -20 degrees C resulted in successful amplification of all DBS specimens by the in house method and only 1 failure using the ViroSeq assay, but amplification of as few as 4 of 6 DPS using either method. Storage at 37 degrees C led to amplification failure by the in house method after 2 weeks using DBS and after 1 week using DPS. No amplification was obtained from either DBS or DPS stored at 37 degrees C and analyzed via the ViroSeq method due to mold growth. In conclusion, for HIV amplification, DBS are preferable to DPS and can be stored with desiccant at 37 degrees C for up to 1 week. Analysis using the in house method was more robust than the ViroSeq assay.

Studies (1)

Purpose

The purpose of this study was to investigate the effects of storage temperature and duration (0-16 weeks) on amplification of HIV from DBS and DPS by two different RT-PCR assays. Importantly, specimens stored at 37 degrees C were exposed to 100% humidity and specimens tested using the in house method were exposed to room temperature overnight prior to the start of the experiment.

Summary of Findings

When DBS were stored at -20 degrees C, amplification was possible in all 6 specimens at all timepoints using the in house assay and in all except for 1 specimen using the ViroSeq assay. DPS stored at -20 degrees C had a higher failure rate with only 4 of 6 specimens allowing for amplification by the in house method after 8 weeks of storage, but interestingly, all 6 were amplified after 16 weeks of storage. Using ViroSeq on DPS stored at -20 degrees C resulted in successful amplification of HIV from only 5 of 6 specimens at each timepoint except after 16 weeks when HIV in only 4 of 6 specimens was amplified. No difference in genotype results between DBS and DPS was found. Storage at 37 degrees C led to amplification failure by the in house method for 2 of 6 DBS specimens after 2 weeks and for 4 of 6 DPS specimens after 1 week. No specimens stored at 37 degrees C were amplified using ViroSeq. The loss of amplification using ViroSeq may be attributable to non-replacement of desiccant which led to mold growth. In conclusion, DBS are preferable to DPS, and specimens can be stored with desiccant at 37 degrees C for up to 1 week. In this study, the in-house method of amplification was more robust then the ViroSeq assay.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    Frozen
  • Diagnoses

    AIDS/HIV-related
  • Platforms

    RNART-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPrognostic factor
    154,620 copies/mL
    179,300 copies/mL
    38,520 copies/mL
    456,200 copies/mL
    570,240 copies/mL
    62,260 copies/mL
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Whole blood
    StorageStorage conditions
    100% humidity with desiccant
    100% humidity with desiccant replacement
    StorageStorage duration
    0 weeks
    1 week
    16 weeks
    2 weeks
    8 weeks
    StorageStorage temperature
    -20 degrees C
    37 degrees C
    StorageTime at room temperature
    None
    Overnight
    RT-PCR SpecificTechnology platform
    In house method
    ViroSeq assay (Abbot)